Oltmans Curtis Gale
Insider CIK 1714982 · ARRY General Counsel · ATXI Director · FULC SVP, General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2026-02-02 | 2026-02-04 | 170,000 | — | $0 | 170,000 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2025-12-15 | 2025-12-17 | 3,452 | $12.92 | $44.6K | 10,252 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2025-01-24 | 2025-01-28 | 225,000 | — | $0 | 225,000 | SEC↗ |
| ATXI AVENUE THERAPEUTICS, INC. | A Award deriv | 2024-09-23 | 2024-09-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2024-01-26 | 2024-01-30 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ATXI AVENUE THERAPEUTICS, INC. | A Award deriv | 2023-06-30 | 2023-07-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2023-04-26 | 2023-04-28 | 127,500 | — | $0 | 127,500 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2023-02-09 | 2023-02-13 | 150,000 | — | $0 | 150,000 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2022-08-09 | 2022-08-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2022-01-19 | 2022-01-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ATXI AVENUE THERAPEUTICS, INC. | A Award | 2021-12-17 | 2021-12-21 | 49,020 | — | $0 | 49,020 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | P Buy | 2021-06-28 | 2021-06-29 | 1,088 | $9.01 | $9.8K | 1,088 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2020-12-03 | 2020-12-07 | 153,600 | — | $0 | 153,600 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-02-05 | 2019-02-07 | 40,000 | — | $0 | 363,900 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2019-02-05 | 2019-02-07 | 40,000 | $8.94 | $357.6K | 55,021 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2019-02-05 | 2019-02-07 | 40,000 | $20.00 | $800.0K | 15,021 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-01-29 | 2019-01-29 | 11,100 | — | $0 | 403,900 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2019-01-29 | 2019-02-07 | 11,100 | $8.94 | $99.2K | 15,021 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-01-25 | 2019-01-29 | 14,029 | — | $0 | 415,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2019-01-25 | 2019-01-29 | 14,029 | $18.00 | $252.5K | 3,921 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2019-01-25 | 2019-01-29 | 14,029 | $8.94 | $125.4K | 17,950 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-01-18 | 2019-01-23 | 1,251 | — | $0 | 429,029 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2019-01-18 | 2019-01-23 | 1,251 | $18.00 | $22.5K | 3,921 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2019-01-18 | 2019-01-23 | 1,251 | $8.94 | $11.2K | 5,172 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-01-15 | 2019-01-17 | 19,720 | — | $0 | 430,280 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2019-01-15 | 2019-01-17 | 19,720 | $18.06 | $356.1K | 3,921 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2019-01-15 | 2019-01-17 | 19,720 | $8.94 | $176.3K | 23,641 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-12-16 | 2018-12-18 | 7,000 | — | $0 | 21,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2018-12-16 | 2018-12-18 | 3,079 | $15.97 | $49.2K | 3,921 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2018-12-16 | 2018-12-18 | 7,000 | — | $0 | 7,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2018-12-14 | 2018-12-18 | 116,250 | — | $0 | 116,250 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2018-12-14 | 2018-12-18 | 19,375 | — | $0 | 19,375 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2017-12-16 | 2017-12-19 | 28,000 | — | $0 | 28,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2017-12-16 | 2017-12-19 | 168,000 | — | $0 | 168,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2017-08-15 | 2018-08-17 | 450,000 | — | $0 | 450,000 | SEC↗ |